相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adiponectin: mechanistic insights and clinical implications
A. T. Turer et al.
DIABETOLOGIA (2012)
Telmisartan increases adiponectin levels: A meta-analysis and meta-regression of randomized head-to-head trials
Hisato Takagi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
The role of adiponectin in human vascular physiology
Aristeidis G. Vaiopoulos et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
The cellular and signaling networks linking the immune system and metabolism in disease
Olivia Osborn et al.
NATURE MEDICINE (2012)
Obesity and disease activity in juvenile idiopathic arthritis
Christina F. Pelajo et al.
PEDIATRIC RHEUMATOLOGY (2012)
Adiponectin Enhances Insulin Sensitivity by Increasing Hepatic IRS-2 Expression via a Macrophage-Derived IL-6-Dependent Pathway
Motoharu Awazawa et al.
CELL METABOLISM (2011)
Lack of association between body mass index and plasma adiponectin levels in healthy adults
S-M Kuo et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
William L. Holland et al.
NATURE MEDICINE (2011)
Diabesity: an overview of a rising epidemic
Youssef M. K. Farag et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1
Masato Iwabu et al.
NATURE (2010)
Inflammatory cytokines in vascular dysfunction and vascular disease
Alexander H. Sprague et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-γ in inflammation in human adipose tissue
R. W. O'Rourke et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
The link between obesity and albuminuria: adiponectin and podocyte dysfunction
Kumar Sharma
KIDNEY INTERNATIONAL (2009)
Adiponectin: from obesity to cardiovascular disease
C. Antoniades et al.
OBESITY REVIEWS (2009)
Oligomerization state-dependent elevations of adiponectin in chronic daily headache
B. Lee Peterlin et al.
NEUROLOGY (2008)
Critical Role of the Endocannabinoid System in the Regulation of Food Intake and Energy Metabolism, with Phylogenetic, Developmental, and Pathophysiological Implications
M. Viveros et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Adiponectin and the metabolic syndrome: mechanisms med ating risk for metabolic and cardiovascular disease
Cristina Lara-Castro et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Adiponectin in health and disease
Deborah K. Oh et al.
DIABETES OBESITY & METABOLISM (2007)
Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle
Weijie Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide
Margaret B. McEntegart et al.
EUROPEAN HEART JOURNAL (2007)
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions
Toshimasa Yamauchi et al.
NATURE MEDICINE (2007)
Adiponectin and cardiovascular disease - Response to therapeutic interventions
Seung Hwan Han et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Serum adiponectin is a predictor of coronary heart disease: A population-based 10-year follow-up study in elderly men
Jan Frystyk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Adiponectin actions in the cardiovascular system
Teresa A. Hopkins et al.
CARDIOVASCULAR RESEARCH (2007)
Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure
Tomohiro Nakamura et al.
CIRCULATION JOURNAL (2006)
Circulating adiponectin concentrations in patients with congestive heart failure
J. George et al.
HEART (2006)
Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain
Erdal Cavusoglu et al.
EUROPEAN HEART JOURNAL (2006)
Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone
H Sell et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms
JA Kim et al.
CIRCULATION (2006)
Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation
YC Fu et al.
JOURNAL OF LIPID RESEARCH (2005)
Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics
MB Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients
C Debard et al.
DIABETOLOGIA (2004)
Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy
C Tentolouris et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2004)
Adiponectin in youth -: relationship to visceral adiposity, insulin sensitivity, and β-cell function
F Bacha et al.
DIABETES CARE (2004)
Adiponectin, obesity, and cardiovascular disease
M Fasshauer et al.
BIOCHIMIE (2004)
Endothelial dysfunction in obesity and insulin resistance: A road to diabetes and heart disease
AE Caballero
OBESITY RESEARCH (2003)
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans
JM Bruun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans
N Stefan et al.
DIABETES (2002)
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes
CC Gerhardt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
分享论文
